A continually expandable foundation model for brain MRI

📅 2026-08-08
📈 Citations: 0
Influential: 0
📄 PDF
🤖 AI Summary
This work proposes Alcmaeon, a continuously extensible 3D foundation model for brain MRI that addresses the limited generalizability and catastrophic forgetting prevalent in existing models, which are often constrained to specific diseases, populations, or imaging protocols. Trained unsupervised on over 425,000 unlabeled brain MRI scans, Alcmaeon incorporates a novel Graph-Blueprint Pruning mechanism that dynamically preserves critical network modules when integrating new clinical domains, thereby mitigating catastrophic forgetting. The model demonstrates consistently lower voxel-level reconstruction forgetting across diverse applications—from healthy aging to tumor imaging—and its hierarchical representations effectively support multiple downstream tasks, including image synthesis, disease classification, survival modeling, and postoperative outcome prediction, while providing interpretable records of capacity allocation.
📝 Abstract
Brain magnetic resonance imaging (MRI) is central to neuroscience and clinical assessment, but models are commonly developed for individual diseases, populations or imaging protocols. Foundation models promise more general representations, yet they are usually pretrained once and can lose earlier capabilities when updated with new data. Here we show that Alcmaeon, a three-dimensional brain MRI foundation model pretrained without manual labels on more than 425,000 volumes and derived imaging maps, can be expanded sequentially across clinical domains. Alcmaeon combines volumetric encoding and latent diffusion generation with Graph-Blueprint Pruning (GBP), which protects network modules important to earlier domains while leaving the remaining capacity trainable. Across expansion from healthy ageing and neurodegeneration to developmental, psychiatric and tumour imaging, GBP showed less forgetting than sequential adaptation and elastic weight consolidation across voxel-level reconstruction measures, with its largest advantage after adaptation to tumour imaging. The blueprints provided an inspectable record of how model capacity was protected and reused. Representations from different model levels supported image synthesis, disease classification, survival modelling and postoperative prediction, although no single representation was optimal for every task. These findings provide a route towards brain MRI foundation models that can grow with emerging data while retaining earlier capabilities.
Problem

Research questions and friction points this paper is trying to address.

foundation model
brain MRI
catastrophic forgetting
continual learning
model expansion
Innovation

Methods, ideas, or system contributions that make the work stand out.

foundation model
continual learning
Graph-Blueprint Pruning
brain MRI
catastrophic forgetting
🔎 Similar Papers
M
Michail Mamalakis
Cancer Research UK Cambridge Institute, University of Cambridge; Department of Computer Science and Technology, University of Cambridge; Department of Psychiatry, University of Cambridge; Department of Psychology, University of Cambridge; Department of Applied Mathematics and Theoretical Physics, University of Cambridge; Department of Oncology, University of Cambridge; Department of Clinical Neuroscience, University of Cambridge
C
Carmen Jimenez-Mesa
Department of Communication Engineering E.T.S. Ingeniería de Telecomunicación, University of Málaga
Y
Yonghao Li
Cancer Research UK Cambridge Institute, University of Cambridge
Hao Chen
Hao Chen
University of Cambridge | Sun Yat-sen University
Multimodel LearningGenerative ModelMedical Imaging Analysis
Chao Li
Chao Li
University of Dundee, University of Cambridge
AI for NeuroscienceAI for Medical Science
A
Antonios Mamalakis
DaSCI Andalusian Institute of Data Science and Computational Intelligence, University of Granada
John Suckling
John Suckling
Department of Psychiatry, University of Cambridge
neuroimagingneurosciencepsychiatry
R
Richard Bethlehem
Department of Psychology, University of Cambridge; Department of Clinical Neuroscience, University of Cambridge
S
Stephen J. Price
Department of Oncology, University of Cambridge; Department of Clinical Neuroscience, University of Cambridge
R
Richard J. Gilbertson
Cancer Research UK Cambridge Institute, University of Cambridge; Department of Oncology, University of Cambridge
P
Pietro Lio
Department of Computer Science and Technology, University of Cambridge; Department of Applied Mathematics and Theoretical Physics, University of Cambridge; School of Data Science, University of Virginia